on NOVACYT (EPA:ALNOV)
Novacyt Announces the Publication of its 2025 Financial Results
Novacyt SA, a molecular diagnostics company, announced that it will publish its audited financial results for 2025 on April 30, 2026. The results presentation will be accompanied by a webinar hosted by Chief Executive Officer Lyn Rees and Chief Financial Officer Steve Gibson. This session for investors will be followed by a Q&A session on the same day at 11:00 GMT. Interested parties can submit their questions in advance and will have access to French subtitles during the presentation.
In addition, a video has been recorded by management to discuss the recent acquisition of Southern Cross Diagnostics Pty Ltd and the associated capital increase. The details of the acquisition and its strategic implications for the company are explained by management in this online video.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news